Home Biosimilar Antibodies Immunology & Inflammation CCR antibody Mogamulizumab (Anti-CCR4 / CD194) For research use only.
Not for use in humans.

Mogamulizumab (Anti-CCR4 / CD194)

Synonyms: KW-0761

Mogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.

Mogamulizumab (Anti-CCR4 / CD194)

Purity & Quality Control

Batch: A256801 Purity: 99% Protein concentration: 6.86mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CCR Inhibitors

Biological Activity

Description Mogamulizumab (Anti-CCR4 / CD194) is a defucosylated humanized recombinant monoclonal antibody targeting CCR4. Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL). MW:145.5 KD.

Product Details

CAS No. 1159266-37-1
Molecular Weight 144.12 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) supplier | purchase Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) cost | Mogamulizumab (Anti-CCR4 / CD194) manufacturer | order Mogamulizumab (Anti-CCR4 / CD194) | Mogamulizumab (Anti-CCR4 / CD194) distributor